National Health Investors (NYSE:NHI) Raised to Hold at Zacks Research

National Health Investors (NYSE:NHI) was upgraded by stock analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a report issued on Tuesday, Zacks reports.

A number of other analysts have also weighed in on the company. Truist Financial lowered their target price on National Health Investors from $81.00 to $80.00 and set a “buy” rating for the company in a report on Wednesday, September 2nd. Huntington assumed coverage on National Health Investors in a research note on Thursday, September 10th. They set an “outperform” rating and a $79.00 price objective for the company. Weiss Ratings lowered National Health Investors from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, September 25th. Deutsche Bank Aktiengesellschaft cut their target price on National Health Investors from $85.00 to $80.00 and set a “hold” rating on the stock in a research note on Thursday, June 25th. Finally, National Bank Financial set a $79.00 price target on shares of National Health Investors in a research report on Wednesday, September 9th. Five research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, National Health Investors currently has an average rating of “Moderate Buy” and an average price target of $82.25.

National Health Investors Trading Down 1.2%

NYSE:NHI opened at $65.84 on Tuesday. National Health Investors has a one year low of $65.51 and a one year high of $91.38. The company has a debt-to-equity ratio of 0.81, a quick ratio of 6.78 and a current ratio of 6.78. The firm has a market cap of $3.23 billion, a P/E ratio of 19.03, a P/E/G ratio of 3.56 and a beta of 0.52. The firm has a 50-day simple moving average of $72.18 and a 200-day simple moving average of $75.79.

National Health Investors (NYSE:NHI) last released its quarterly earnings data on Monday, August 10th. The real estate investment trust reported $1.19 earnings per share (EPS) for the quarter. National Health Investors had a net margin of 38.56% and a return on equity of 10.89%. The firm had revenue of $121.32 million for the quarter. During the same quarter in the prior year, the business posted $1.22 earnings per share. National Health Investors’s revenue for the quarter was up 1.6% on a year-over-year basis. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. Equities analysts anticipate that National Health Investors will post 4.76 EPS for the current fiscal year.

Institutional Trading of National Health Investors

Institutional investors have recently made changes to their positions in the business. Deutsche Bank AG acquired a new position in National Health Investors during the 2nd quarter valued at about $9,252,000. Forty three Eighteen Advisors LLC acquired a new stake in National Health Investors in the first quarter worth about $2,005,000. Bank of America Corp DE acquired a new stake in National Health Investors in the second quarter worth about $77,738,000. Public Employees Retirement System of Ohio purchased a new stake in shares of National Health Investors during the second quarter worth about $4,243,000. Finally, Principal Financial Group Inc. grew its stake in shares of National Health Investors by 2.0% during the first quarter. Principal Financial Group Inc. now owns 1,700,908 shares of the real estate investment trust’s stock worth $137,537,000 after acquiring an additional 32,902 shares during the last quarter. Institutional investors and hedge funds own 62.51% of the company’s stock.

National Health Investors Company Profile

National Health Investors, Inc (NYSE:NHI) is a self-managed real estate investment trust that owns and finances healthcare-related real estate. The company primarily invests in properties used by seniors and patients, including senior housing communities, skilled nursing facilities, medical office buildings and other healthcare facilities.

NHI generally leases its properties to healthcare operators under long-term agreements and may provide mortgage or other financing to support the development and operation of healthcare real estate.